↗5 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$81KBought on the market
$0.00Sold on the market
1Companies
Oct 22, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 202617:44 | Oct 22, 2026 | ANIXAnixa Biosciences Inc | Chief Executive Officer, Director | P · Buy | $2.72 | +8,000 | 680,000 | +1% | +$22K | -26.7% | +21.3% |
| Sep 28, 202608:45 | Sep 24, 2026 | ANIXAnixa Biosciences Inc | Chief Executive Officer, Director | P · Buy | $2.78 | +7,000 | 672,000 | +1% | +$19K | -25.9% | +18.7% |
| Sep 14, 202609:45 | Sep 10, 2026 | ANIXAnixa Biosciences Inc | Chief Executive Officer, Director | P · Buy | $2.75 | +3,000 | 665,000 | +0% | +$8K | -26.7% | +20.0% |
| Sep 11, 202608:00 | Sep 10, 2026 | ANIXAnixa Biosciences Inc | Chief Executive Officer, Director | P · Buy | $2.76 | +5,000 | 662,000 | +1% | +$14K | -26.4% | +19.6% |
| Aug 3, 202608:45 | Jul 31, 2026 | ANIXAnixa Biosciences Inc | Chief Executive Officer, Director | P · Buy | $3.47 | +5,000 | 657,000 | +1% | +$17K | -7.5% | -4.9% |